Icon (ICLR) Stock Forecast & Price Target

Compare

512 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ICLR Analyst Ratings

Moderate Buy

10 Buy

5 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Icon

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ICLR Stock 12 Month Forecast

Average Price Target

$210.23

▲(21.43% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Icon in the last 3 months. The average price target is $210.23 with a high forecast of $240.00 and a low forecast of $155.00. The average price target represents a 21.43% change from the last price of $173.13.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"127":"$127","176":"$176","225":"$225","274":"$274","323":"$323"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":240,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$240.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":210.23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$210.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":155,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$155.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[127,176,225,274,323],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,177.84,182.62153846153848,187.40307692307692,192.1846153846154,196.96615384615384,201.74769230769232,206.52923076923076,211.31076923076924,216.09230769230768,220.87384615384616,225.6553846153846,230.43692307692308,235.21846153846155,{"y":240,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,177.84,180.33153846153846,182.8230769230769,185.3146153846154,187.80615384615385,190.2976923076923,192.78923076923076,195.28076923076924,197.7723076923077,200.26384615384615,202.7553846153846,205.24692307692308,207.73846153846154,{"y":210.23,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,177.84,176.08307692307693,174.32615384615386,172.56923076923078,170.81230769230768,169.0553846153846,167.29846153846154,165.54153846153847,163.7846153846154,162.02769230769232,160.27076923076925,158.51384615384615,156.75692307692307,{"y":155,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":322.06,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":284.51,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":220.4,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":213.56,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":209.71,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":199.08,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":190.02,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":166.56,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.21,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.9,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.88,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":166.44,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.84,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$240.00

Average Price Target$210.23

Lowest Price Target$155.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ann Hynes

Mizuho Securities

$225

Buy

29.96%

Upside

Reiterated

09/16/25

Mizuho Securities Remains a Buy on Icon (ICLR)We reiterate our Outperform rating and price target of $225.

Charles Rhyee

TD Cowen

$209→$183

Hold

5.70%

Upside

Reiterated

09/12/25

Icon price target lowered to $183 from $209 at TD CowenIcon price target lowered to $183 from $209 at TD Cowen

Cira Diagnissa

TR | OpenAI - 4o

$187→$194

Buy

12.05%

Upside

Reiterated

09/12/25

AI Generated ArticleAI Generated Article

David Windley

Jefferies

$220→$175

Hold

1.08%

Upside

Downgraded

09/08/25

Icon downgraded to Hold from Buy at JefferiesIcon downgraded to Hold from Buy at Jefferies

Jailendra Singh

Truist Financial

―

Buy

―

Reiterated

09/05/25

Truist Financial Reaffirms Their Buy Rating on Icon (ICLR)

Michael Cherny

Leerink Partners

$235

Buy

35.74%

Upside

Reiterated

09/04/25

Buy Rating Affirmed for Icon Amid CEO Transition and Market ChallengesWe view his experience across the enterprise as valuable, as ICLR navigates a dynamic demand backdrop and continues to ink partnerships with large pharma. ICLR's recent operating challenges related to elevated cancellations are not drastically different from the rest of the market directionally, even if the magnitude was a tad higher because of the specific BARDA trial exposure. Either way, we think ICLR has been navigating an unprecedented level of uncertainty as best as possible and should be well-positioned as market conditions improve. Today's CEO transition should not change that dynamic. We continue to see ICLR shares as overly discounted to intrinsic value and reiterate our Outperform rating.

Michael Ryskin

Bank of America Securities

$220

Buy

27.07%

Upside

Reiterated

09/04/25

Strategic Leadership Transition and Market Resilience Underpin Buy RatingBofA Securities analyst Derik de Bruin reiterated a Buy rating and $220.00 price target on ICON plc (NASDAQ: ICLR).

Max Smock

William Blair

―

Buy

―

Reiterated

09/04/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Icon (NASDAQ: ICLR)We view the following as key risks for ICON: 1) a slowdown in the R&D spending environment due to lower end-market pricing or other exogenousfactors; 2) a material reduction in the amount of biotech funding; and 3) increased pricing pressure in the clinical CRO industry. Blair | Building | 150 North Riverside Plaza | Chicago, IL 60606 | +1 312 236 1600 | www.williamblair.com This is not in any sense a solicitation or offer of the purchase or sale of securities. The factual statements herein have been taken from sources we believe to be reliable, but such statements are made without any representation as to accuracy or completeness or otherwise. Opinions expressed are our own unless otherwise stated. Prices shown are approximate.

Jamie Clark

Redburn Atlantic

$184→$236

Buy

36.31%

Upside

Upgraded

09/03/25

Positive Report for Icon (ICLR) from Redburn Atlantic

Eric Coldwell

Robert W. Baird

$222→$224

Buy

29.38%

Upside

Reiterated

09/02/25

Icon price target raised to $224 from $222 at BairdIcon price target raised to $224 from $222 at Baird

Patrick B Donnelly

Citi

$225→$200

Hold

15.52%

Upside

Downgraded

08/21/25

Icon downgraded to Neutral from Buy at CitiIcon downgraded to Neutral from Buy at Citi

Elizabeth Anderson CFA

Evercore ISI

$240

Buy

38.62%

Upside

Reiterated

08/13/25

Icon (ICLR) Gets a Buy from Evercore ISI

George Hill

Deutsche Bank

$200→$210

Buy

21.30%

Upside

Reiterated

07/29/25

Deutsche Bank Reaffirms Their Buy Rating on Icon (ICLR)Deutsche Bank analyst George Hill raised the price target on ICON plc (NASDAQ: ICLR) to $210.00 (from $200.00) while maintaining a Buy rating.

John Sourbeer

UBS

$170→$240

Buy

38.62%

Upside

Reiterated

07/25/25

Icon (ICLR) Gets a Buy from UBS

Casey Woodring

J.P. Morgan

$190

Hold

9.74%

Upside

Reiterated

07/24/25

Analysts Conflicted on These Healthcare Names: Icon (NASDAQ: ICLR) and Veeva Systems (NYSE: VEEV)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ann Hynes

Mizuho Securities

$225

Buy

29.96%

Upside

Reiterated

09/16/25

Mizuho Securities Remains a Buy on Icon (ICLR)We reiterate our Outperform rating and price target of $225.

Charles Rhyee

TD Cowen

$209→$183

Hold

5.70%

Upside

Reiterated

09/12/25

Icon price target lowered to $183 from $209 at TD CowenIcon price target lowered to $183 from $209 at TD Cowen

Cira Diagnissa

TR | OpenAI - 4o

$187→$194

Buy

12.05%

Upside

Reiterated

09/12/25

AI Generated ArticleAI Generated Article

David Windley

Jefferies

$220→$175

Hold

1.08%

Upside

Downgraded

09/08/25

Icon downgraded to Hold from Buy at JefferiesIcon downgraded to Hold from Buy at Jefferies

Jailendra Singh

Truist Financial

―

Buy

―

Reiterated

09/05/25

Truist Financial Reaffirms Their Buy Rating on Icon (ICLR)

Michael Cherny

Leerink Partners

$235

Buy

35.74%

Upside

Reiterated

09/04/25

Michael Ryskin

Bank of America Securities

$220

Buy

27.07%

Upside

Reiterated

09/04/25

Strategic Leadership Transition and Market Resilience Underpin Buy RatingBofA Securities analyst Derik de Bruin reiterated a Buy rating and $220.00 price target on ICON plc (NASDAQ: ICLR).

Max Smock

William Blair

―

Buy

―

Reiterated

09/04/25

Jamie Clark

Redburn Atlantic

$184→$236

Buy

36.31%

Upside

Upgraded

09/03/25

Positive Report for Icon (ICLR) from Redburn Atlantic

Eric Coldwell

Robert W. Baird

$222→$224

Buy

29.38%

Upside

Reiterated

09/02/25

Icon price target raised to $224 from $222 at BairdIcon price target raised to $224 from $222 at Baird

Patrick B Donnelly

Citi

$225→$200

Hold

15.52%

Upside

Downgraded

08/21/25

Icon downgraded to Neutral from Buy at CitiIcon downgraded to Neutral from Buy at Citi

Elizabeth Anderson CFA

Evercore ISI

$240

Buy

38.62%

Upside

Reiterated

08/13/25

Icon (ICLR) Gets a Buy from Evercore ISI

George Hill

Deutsche Bank

$200→$210

Buy

21.30%

Upside

Reiterated

07/29/25

Deutsche Bank Reaffirms Their Buy Rating on Icon (ICLR)Deutsche Bank analyst George Hill raised the price target on ICON plc (NASDAQ: ICLR) to $210.00 (from $200.00) while maintaining a Buy rating.

John Sourbeer

UBS

$170→$240

Buy

38.62%

Upside

Reiterated

07/25/25

Icon (ICLR) Gets a Buy from UBS

Casey Woodring

J.P. Morgan

$190

Hold

9.74%

Upside

Reiterated

07/24/25

Analysts Conflicted on These Healthcare Names: Icon (NASDAQ: ICLR) and Veeva Systems (NYSE: VEEV)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Icon

1 Month

xxx

Success Rate

23/40 ratings generated profit

Average Return

+0.83%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 57.50% of your transactions generating a profit, with an average return of +0.83% per trade.

3 Months

xxx

Success Rate

22/40 ratings generated profit

Average Return

+3.33%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 55.00% of your transactions generating a profit, with an average return of +3.33% per trade.

1 Year

Eric ColdwellRobert W. Baird

Success Rate

23/40 ratings generated profit

Average Return

+8.67%

reiterated a buy rating 17 days ago

Copying Eric Coldwell's trades and holding each position for 1 Year would result in 57.50% of your transactions generating a profit, with an average return of +8.67% per trade.

2 Years

xxx

Success Rate

25/40 ratings generated profit

Average Return

+11.48%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +11.48% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ICLR Analyst Recommendation Trends

Rating

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ICLR has received 34 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. ICLR average Analyst price target in the past 3 months is 210.23.

Each month's total comprises the sum of three months' worth of ratings.

ICLR Financial Forecast

ICLR Earnings Forecast

Next quarter’s earnings estimate for ICLR is $3.31 with a range of $3.18 to $3.43. The previous quarter’s EPS was $3.26. ICLR beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.20% of the time in the same period. In the last calendar year ICLR has Outperformed its overall industry.

ICLR Sales Forecast

Next quarter’s sales forecast for ICLR is $1.98B with a range of $1.91B to $2.04B. The previous quarter’s sales results were $2.02B. ICLR beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.14% of the time in the same period. In the last calendar year ICLR has Outperformed its overall industry.

ICLR Stock Forecast FAQ

What is ICLR’s average 12-month price target, according to analysts?

Based on analyst ratings, Icon plc’s 12-month average price target is 210.23.

What is ICLR’s upside potential, based on the analysts’ average price target?

Icon plc has 21.43% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ICLR a Buy, Sell or Hold?

Icon plc has a consensus rating of Moderate Buy which is based on 10 buy ratings, 5 hold ratings and 0 sell ratings.

What is Icon plc’s price target?

The average price target for Icon plc is 210.23. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $240.00 ,the lowest forecast is $155.00. The average price target represents 21.43% Increase from the current price of $173.13.

What do analysts say about Icon plc?

Icon plc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of ICLR?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Icon (ICLR) Stock Forecast & Price Target

ICLR Analyst Ratings

ICLR Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Icon

ICLR Analyst Recommendation Trends

ICLR Financial Forecast

ICLR Earnings Forecast

ICLR Sales Forecast

ICLR Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts